These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3484675)

  • 1. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
    Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
    Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
    Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
    J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response by biological response modifiers.
    Chirigos MA; Schlick E; Budzynski W
    Cancer Detect Prev Suppl; 1987; 1():385-97. PubMed ID: 3500779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers.
    Saito T; Ruffman R; Welker RD; Herberman RB; Chirigos MA
    Cancer Immunol Immunother; 1985; 19(2):130-5. PubMed ID: 3845849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of MVE-2 and poly ICLC.
    Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
    Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.
    Saito T; Welker RD; Fukui H; Herberman RB; Chirigos MA
    Cell Immunol; 1985 Feb; 90(2):577-89. PubMed ID: 3871375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
    Piccoli M; Saito T; Chirigos MA
    Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in liver-associated natural killer activity by polyribonucleotides.
    Twilley TA; Mason L; Talmadge JE; Wiltrout RH
    Nat Immun Cell Growth Regul; 1987; 6(6):279-90. PubMed ID: 3448488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation of natural killer activity by polyribonucleotides.
    Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
    J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
    Chirigos MA; Schlick E; Saito T; Gruys E
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):27-33. PubMed ID: 3486334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
    Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
    Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
    Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA
    Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
    Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.
    Chirigos MA; Welker R; Schlick E; Saito T; Ruffmann R
    Prog Clin Biol Res; 1984; 161():467-79. PubMed ID: 6483899
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.
    Budzynski W; Chirigos M; Gruys E
    Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation in cytotoxicity of lymphnode lymphocytes by OK-432.
    Tanaka N; Gotoh K; Kobayashi G; Gouchi A; Orita K
    Int J Immunopharmacol; 1994 Feb; 16(2):131-5. PubMed ID: 8181902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.